Ian Bradbury
Overview
Explore the profile of Ian Bradbury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
2301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
McCaughan E, Parahoo K, Hueter I, Northouse L, Bradbury I
Cochrane Database Syst Rev
. 2017 Mar;
3:CD011652.
PMID: 28278559
Background: Survival rates for women with a diagnosis of breast cancer continue to improve. However, some women may experience physical, psychological and emotional effects post diagnosis, throughout treatment and beyond....
22.
ONeill K, Moran F, Tunney M, Elborn J, Bradbury I, Downey D, et al.
BMJ Open Respir Res
. 2017 Jan;
4(1):e000168.
PMID: 28123751
Background: Streamlining the timing of treatments in cystic fibrosis (CF) is important to optimise adherence while ensuring efficacy. The optimal timing of treatment with hypertonic saline (HTS) and airway clearance...
23.
Lighten J, Incarnato D, Ward B, Van Oosterhout C, Bradbury I, Hanson M, et al.
R Soc Open Sci
. 2016 Nov;
3(10):160299.
PMID: 27853546
The relative importance of genetic versus epigenetic changes in adaptive evolution is a hotly debated topic, with studies showing that some species appear to be able to adapt rapidly without...
24.
Fumagalli D, Venet D, Ignatiadis M, Azim Jr H, Maetens M, Rothe F, et al.
JAMA Oncol
. 2016 Sep;
3(2):227-234.
PMID: 27684533
Importance: In neoadjuvant trials, treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancers with dual HER2 blockade resulted in increased pathologic complete response (pCR) rates compared with each...
25.
ONeill K, Tunney M, Johnston E, Rowan S, Downey D, Rendall J, et al.
Chest
. 2016 Jul;
150(6):1323-1332.
PMID: 27395423
Background: Lung clearance index (LCI) has good clinimetric properties and an acceptable feasibility profile as a surrogate end point in cystic fibrosis (CF). Although most studies to date have been...
26.
Sonnenblick A, de Azambuja E, Agbor-Tarh D, Bradbury I, Campbell C, Huang Y, et al.
J Natl Cancer Inst
. 2016 Apr;
108(8).
PMID: 27098150
Background: Previously we have shown that early development of rash is associated with a higher chance of achieving pathological complete response to neoadjuvant lapatinib. In the current analysis, we investigate...
27.
Pentieva K, Selhub J, Paul L, Molloy A, McNulty B, Ward M, et al.
J Nutr
. 2016 Jan;
146(3):494-500.
PMID: 26817717
Background: Exposure to higher intakes of folic acid (FA) from fortified foods and supplements, although largely considered beneficial, is associated with unmetabolized FA in the circulation, which has raised some...
28.
Hegedus E, McDonough S, Bleakley C, Baxter G, DePew J, Bradbury I, et al.
Br J Sports Med
. 2016 Jan;
50(21):1333-1337.
PMID: 26746910
Background: The ability to predict injury is difficult. Prior injury is the only risk factor that has been reported consistently in multiple research studies. Convenient and easy to perform, physical...
29.
Wilson J, Kirk A, Hayes K, Bradbury I, McDonough S, Tully M, et al.
Respir Care
. 2015 Dec;
61(1):68-77.
PMID: 26647454
Background: The transtheoretical model has been successful in promoting health behavior change in general and clinical populations. However, there is little knowledge about the application of the transtheoretical model to...
30.
OSullivan C, Holmes E, Campbell C, Bradbury I, Zujewski J, Gelber R
J Clin Oncol
. 2015 Dec;
34(6):640-1.
PMID: 26644531
No abstract available.